Cargando…
A prospective analysis of robotic targeted MRI-US fusion prostate biopsy using the centroid targeting approach
Robotic prostate biopsy is an emerging technology. Recent development of this tool has allowed the performance of a transperineal prostate biopsy allowing pre-programmed standardized biopsy schemes. Prospective data collection was undertaken in 86 consecutive men who underwent robotically assisted t...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000504/ https://www.ncbi.nlm.nih.gov/pubmed/30783886 http://dx.doi.org/10.1007/s11701-019-00929-y |
_version_ | 1783494056141127680 |
---|---|
author | Miah, Saiful Servian, Pol Patel, Amit Lovegrove, Catherine Skelton, Lindsey Shah, Taimur T. Eldred-Evans, David Arya, Manit Tam, Henry Ahmed, Hashim U. Winkler, Mathias |
author_facet | Miah, Saiful Servian, Pol Patel, Amit Lovegrove, Catherine Skelton, Lindsey Shah, Taimur T. Eldred-Evans, David Arya, Manit Tam, Henry Ahmed, Hashim U. Winkler, Mathias |
author_sort | Miah, Saiful |
collection | PubMed |
description | Robotic prostate biopsy is an emerging technology. Recent development of this tool has allowed the performance of a transperineal prostate biopsy allowing pre-programmed standardized biopsy schemes. Prospective data collection was undertaken in 86 consecutive men who underwent robotically assisted transperineal prostate biopsy. All underwent a multi-parametric MRI pre-biopsy with centroid targeting followed by systematic template prostate biopsy. For the purposes of this study, our definition of clinically significant prostate cancer (csPCa) is any Gleason score > 6. Mean (SD) age, median (IQR) PSA, and median (IQR) prostate volume were 64.24 (6.97) years, of 7.79 ng/ml (6.5) and 45.06 cc (28), respectively. Overall, 44 (51.2%) men were diagnosed with csPCa. csPCa was detected in the targeted biopsies alone in 35 (40.1%) men. The addition of the 12-zone template biopsy increased the yield of csPCa for another 9 (10.5%) men. Of these 9 men, the majority (7) harbored primary pattern 3 disease and only 1 was identified to have high-grade disease. Out of these 9 men, 7 of them had the identification of csPCa in the sector, where a target was contained within that zone. Robotic-assisted prostate biopsy in our study has demonstrated a high detection of csPCa when combined with limited near-field sampling. Our study suggests the use of more accurate biopsy schemes such as ring-targeting of lesions to mitigate against systematic and random mathematical errors. Adoption of this tool and biopsy strategy would potentially avoid the increased morbidity associated with whole gland systematic unguided biopsies. |
format | Online Article Text |
id | pubmed-7000504 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer London |
record_format | MEDLINE/PubMed |
spelling | pubmed-70005042020-02-21 A prospective analysis of robotic targeted MRI-US fusion prostate biopsy using the centroid targeting approach Miah, Saiful Servian, Pol Patel, Amit Lovegrove, Catherine Skelton, Lindsey Shah, Taimur T. Eldred-Evans, David Arya, Manit Tam, Henry Ahmed, Hashim U. Winkler, Mathias J Robot Surg Original Article Robotic prostate biopsy is an emerging technology. Recent development of this tool has allowed the performance of a transperineal prostate biopsy allowing pre-programmed standardized biopsy schemes. Prospective data collection was undertaken in 86 consecutive men who underwent robotically assisted transperineal prostate biopsy. All underwent a multi-parametric MRI pre-biopsy with centroid targeting followed by systematic template prostate biopsy. For the purposes of this study, our definition of clinically significant prostate cancer (csPCa) is any Gleason score > 6. Mean (SD) age, median (IQR) PSA, and median (IQR) prostate volume were 64.24 (6.97) years, of 7.79 ng/ml (6.5) and 45.06 cc (28), respectively. Overall, 44 (51.2%) men were diagnosed with csPCa. csPCa was detected in the targeted biopsies alone in 35 (40.1%) men. The addition of the 12-zone template biopsy increased the yield of csPCa for another 9 (10.5%) men. Of these 9 men, the majority (7) harbored primary pattern 3 disease and only 1 was identified to have high-grade disease. Out of these 9 men, 7 of them had the identification of csPCa in the sector, where a target was contained within that zone. Robotic-assisted prostate biopsy in our study has demonstrated a high detection of csPCa when combined with limited near-field sampling. Our study suggests the use of more accurate biopsy schemes such as ring-targeting of lesions to mitigate against systematic and random mathematical errors. Adoption of this tool and biopsy strategy would potentially avoid the increased morbidity associated with whole gland systematic unguided biopsies. Springer London 2019-02-19 2020 /pmc/articles/PMC7000504/ /pubmed/30783886 http://dx.doi.org/10.1007/s11701-019-00929-y Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Miah, Saiful Servian, Pol Patel, Amit Lovegrove, Catherine Skelton, Lindsey Shah, Taimur T. Eldred-Evans, David Arya, Manit Tam, Henry Ahmed, Hashim U. Winkler, Mathias A prospective analysis of robotic targeted MRI-US fusion prostate biopsy using the centroid targeting approach |
title | A prospective analysis of robotic targeted MRI-US fusion prostate biopsy using the centroid targeting approach |
title_full | A prospective analysis of robotic targeted MRI-US fusion prostate biopsy using the centroid targeting approach |
title_fullStr | A prospective analysis of robotic targeted MRI-US fusion prostate biopsy using the centroid targeting approach |
title_full_unstemmed | A prospective analysis of robotic targeted MRI-US fusion prostate biopsy using the centroid targeting approach |
title_short | A prospective analysis of robotic targeted MRI-US fusion prostate biopsy using the centroid targeting approach |
title_sort | prospective analysis of robotic targeted mri-us fusion prostate biopsy using the centroid targeting approach |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000504/ https://www.ncbi.nlm.nih.gov/pubmed/30783886 http://dx.doi.org/10.1007/s11701-019-00929-y |
work_keys_str_mv | AT miahsaiful aprospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT servianpol aprospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT patelamit aprospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT lovegrovecatherine aprospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT skeltonlindsey aprospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT shahtaimurt aprospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT eldredevansdavid aprospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT aryamanit aprospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT tamhenry aprospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT ahmedhashimu aprospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT winklermathias aprospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT miahsaiful prospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT servianpol prospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT patelamit prospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT lovegrovecatherine prospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT skeltonlindsey prospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT shahtaimurt prospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT eldredevansdavid prospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT aryamanit prospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT tamhenry prospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT ahmedhashimu prospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach AT winklermathias prospectiveanalysisofrobotictargetedmriusfusionprostatebiopsyusingthecentroidtargetingapproach |